Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Farrell

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Inflammatory Bowel Diseases|May 23, 2002
Crohn's disease: not all anti-TNFs are the same!Richard J Farrell
The New England Journal of Medicine|July 25, 2003
Epidermal growth factor for ulcerative colitisRichard J Farrell
The New England Journal of Medicine|September 26, 2019
Biologics beyond Anti-TNF Agents for Ulcerative Colitis - Efficacy, Safety, and Cost?Richard J Farrell
JAMA|May 19, 2005
Infant gluten and celiac disease: too early, too late, too much, too many questionsRichard J Farrell
Inflammatory Bowel Diseases|December 24, 2005
From SNPs to haplotypes: unraveling the role of MDR1 in IBDSeema Maroo, Richard J Farrell
The New England Journal of Medicine|January 18, 2002
Celiac sprueRichard J Farrell, Ciarán P Kelly
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 13, 2005
Endoscopy in inflammatory bowel disease: indications, surveillance, and use in clinical practiceDavid S Fefferman, Richard J Farrell
Critical Reviews in Oncology/Hematology|June 28, 2005
The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agentsJohn H Kwon, Richard J Farrell
Gastroenterology|April 19, 2006
Lymphoma risk with azathioprine/6-MP therapy-read beyond the headlinesAlan C Moss, Richard J Farrell
Gastroenterology|October 28, 2006
Infliximab for induction and maintenance therapy for ulcerative colitisAlan C Moss, Richard J Farrell
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Inflammatory Bowel Diseases|May 23, 2002
Crohn's disease: not all anti-TNFs are the same!Richard J Farrell
The New England Journal of Medicine|July 25, 2003
Epidermal growth factor for ulcerative colitisRichard J Farrell
The New England Journal of Medicine|September 26, 2019
Biologics beyond Anti-TNF Agents for Ulcerative Colitis - Efficacy, Safety, and Cost?Richard J Farrell
JAMA|May 19, 2005
Infant gluten and celiac disease: too early, too late, too much, too many questionsRichard J Farrell
Inflammatory Bowel Diseases|December 24, 2005
From SNPs to haplotypes: unraveling the role of MDR1 in IBDSeema Maroo, Richard J Farrell
The New England Journal of Medicine|January 18, 2002
Celiac sprueRichard J Farrell, Ciarán P Kelly
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 13, 2005
Endoscopy in inflammatory bowel disease: indications, surveillance, and use in clinical practiceDavid S Fefferman, Richard J Farrell
Critical Reviews in Oncology/Hematology|June 28, 2005
The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agentsJohn H Kwon, Richard J Farrell
Gastroenterology|April 19, 2006
Lymphoma risk with azathioprine/6-MP therapy-read beyond the headlinesAlan C Moss, Richard J Farrell
Gastroenterology|October 28, 2006
Infliximab for induction and maintenance therapy for ulcerative colitisAlan C Moss, Richard J Farrell
Pageof 4